Search

Search Constraints

You searched for: Author/Creator Berman, Sarah

Search Results

2. [F3–01–04]: LONGITUDINAL BIOMARKER CHANGES IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE FROM THE DIAN STUDY. (1st July 2017)

3. P3‐214: DEMENTIA WITH LEWY BODIES CONSORTIUM: METHODOLOGY AND INITIAL SUBJECT CHARACTERISTICS. (1st July 2006)

4. O5‐02‐01: Longitudinal Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease: The Dominantly Inherited Alzheimer Network. (1st July 2016)

6. Ambient fine particulate matter exposure and incident mild cognitive impairment and dementia. Issue 8 (26th April 2021)

7. The complexity of DLB: U.S.‐based Dementia with Lewy Body Consortium: Biomarkers and early diagnosis of DLB: New findings. (7th December 2020)

8. Overview of dominantly inherited AD and top‐line DIAN‐TU results of solanezumab and gantenerumab: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD. (7th December 2020)

9. Solanezumab in‐depth outcomes: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD. (7th December 2020)

10. Gantenerumab in‐depth outcomes: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD. (7th December 2020)